According to a recent LinkedIn post from ABM Respiratory Care, the company plans to showcase its BiWaze platform at upcoming regional respiratory society conferences in Denver and Southern California. The post highlights in‑person demonstrations of BiWaze Clear and BiWaze Cough and points clinicians to online resources and demo scheduling for those unable to attend.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests a targeted commercial push toward respiratory therapists and clinical decision makers, a key audience for capital equipment and recurring disposables. Increased visibility at specialty conferences may support lead generation, deepen clinical adoption, and potentially strengthen the company’s competitive position in airway clearance, which could translate into higher future sales if conversion from demonstrations to orders is successful.
Participation in state-level professional meetings also indicates ongoing investment in market development rather than broad consumer marketing. For investors, this focus may imply a strategy centered on clinician-driven adoption and evidence-based positioning in respiratory care, which could be important for long-term revenue stability and potential partnerships with health systems or distributors.